Tissue or biological heart valve is made from animal tissue, such as porcine (pig) or bovine (cow), as it is similar to human tissue. Tissue heart valves need chemical treatment for protection and stent or frame for support. Tissue heart valves can last up to 10 to 20 years.? The global tissue heart valves market is expected to grow substantially due to high prevalence of heart valve diseases, which is constantly rising due to socioeconomic factors, such as lifestyle-induced dietary, physical inactivity, and certain other habits, including smoking. Moreover, longer life expectancy of the geriatric population boosts the growth of the tissue heart valves market. As per a report of the National Institutes of Health (NIH), 8.5% of the world population is aged 65 or above, and it is anticipated to rise to nearly 17% by 2050. In addition, increase in demand for minimally invasive procedures and technological advancements are projected to propel the growth of the tissue heart valves market during the forecast period. On the other hand, stringent government approval process and high price of minimally invasive procedures are hindering the market growth. Nevertheless, huge unmet needs in the emerging markets and advanced treatment of valvular diseases are expected to create opportunities for the tissue heart valve market. The Americas is expected to account for almost most of the total market share by 2023. The high incidence of heart valve diseases, such as such as aortic valve degeneration, and aortic stenosis, in this region, is a critical factor that will spur market growth until the end of the forecast period. Furthermore, a rise in the aging population will also augment the demand for tissue heart valves in the region. The global Tissue Heart Valves market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Tissue Heart Valves volume and value at global level, regional level and company level. From a global perspective, this report represents overall Tissue Heart Valves market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Tissue Heart Valves in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Tissue Heart Valves manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market. The following manufacturers are covered: Edwards Lifesciences Medtronic St. Jude Medical Abbott Colibri Heart Valve CryoLife Labcor Laboratorios ... Segment by Regions North America Europe China Japan Southeast Asia India Segment by Type Stented Tissue Heart Valves Stentless Tissue Heart Valves Segment by Application Hospitals Clinics Others
Table of Contents Executive Summary 1 Industry Overview of Tissue Heart Valves 1.1 Definition of Tissue Heart Valves 1.2 Tissue Heart Valves Segment by Type 1.2.1 Global Tissue Heart Valves Production Growth Rate Comparison by Types (2014-2025) 1.2.2 Stented Tissue Heart Valves 1.2.3 Stentless Tissue Heart Valves 1.3 Tissue Heart Valves Segment by Appl
